CytoDyn Inc.

CYDY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $1.2M $1.8M $9.6M $1.1M $4.9M $603.7K $285.0K $1.0M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $3.3M $6.1M $11.5M $2.0M $5.4M $840.5K $1.0M $2.0M
Property, Plant & Equipment $11.2K $17.3K $24.6K $24.2K $16.8K — $800 $5.4K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $1.6M $1.9M $2.3M $2.6M $3.0M $3.3M $38.6K —
Total Assets $4.9M $8.1M $13.8M $4.7M $8.4M $4.2M $1.1M $2.0M
Liabilities
Accounts Payable $15.8M $4.3M $2.5M $5.0M $1.3M $1.1M $831.3K $933.0K
Total Current Liabilities $16.7M $6.1M $3.6M $10.7M $2.2M $3.2M $5.0M $7.0M
Long-Term Debt — — — $43.5K $2.3M $1.2M — —
Total Liabilities $18.1M $9.2M $3.6M $15.4M $4.5M $4.4M $5.0M $7.0M
Stockholders' Equity
Retained Earnings $-173.1M $-123.0M $-97.2M $-71.5M $-46.4M $-34.0M — —
Total Stockholders' Equity $-13.2M $-1.1M $10.2M $-10.7M $3.9M $-223.9K $-4.0M $-5.0M
← Newer Page 2 of 2 Older →